Dual action antimicrobial surfaces via combined nitric oxide and silver release

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 6, 2015, Pages 1974-1984

  Storm, Wesley L ^a   Johnson, Justin A ^a   Worley, Brittany V ^a   Slomberg, Danielle L ^a   Schoenfisch, Mark H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

active release; antimicrobial; combination therapy; nitric oxide; silver nitrate; sol gel

Indexed keywords

BACTERIA; CELL CULTURE; MAMMALS; MICROORGANISMS; NITRATES; NITRIC OXIDE; SILVER ALLOYS; SOL-GEL PROCESS; SOL-GELS; XEROGELS;

ACTIVE RELEASE; ANTIMICROBIAL; ANTIMICROBIAL SURFACE; COMBINATION THERAPY; PSEUDOMONAS AERUGINOSA; SILVER NITRATES; SILVER SULFADIAZINES; STAPHYLOCOCCUS AUREUS;

SILVER;

AMINE; NITRIC OXIDE; SILICON DIOXIDE; SILVER NITRATE; ANTIINFECTIVE AGENT; GEL; SILVER;

ANIMAL CELL; ARTICLE; BACTERIAL COUNT; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BACTERIUM COLONY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; EXPOSURE; FIBROBLAST; MOUSE; NONHUMAN; PRESSURE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; SYNTHESIS; XEROGEL; ANIMAL; CELL DEATH; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GEL; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; TOXICITY;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL DEATH; CELL LINE; COLONY COUNT, MICROBIAL; FIBROBLASTS; GELS; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, FLUORESCENCE; NITRIC OXIDE; PSEUDOMONAS AERUGINOSA; SILVER; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

EID: 84928560454     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35331     Document Type: Article

References (48)

1. Schierholz JM, Beuth J,. Implant infections: A haven for opportunistic bacteria. J Hosp Infect 2001; 49: 87-93.
2. Gristina AG,. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res 1994; 298: 106-118.
3. Toole GO, Kaplan HB, Kolter R,. Biofilm formation as microbial development. Annu Rev Microbiol 2000; 54: 49-79.
4. Stewart PS, Costerton JW,. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-138.
5. Epstein AK, Pokroy B, Seminara A, Aizenberg J,. Bacterial biofilm shows persistent resistance to liquid wetting and gas penetration. Proc Nat Acad Sci USA 2010; 108: 995-1000.
6. Zimmerli W,. Infection and musculoskeletal conditions: Prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 2006; 20: 1045-1063.
7. Costerton JW,. Bacterial biofilms: A common cause of persistent infections. Science 1999; 284: 1318-1322.
8. Hetrick EM, Schoenfisch MH,. Reducing implant-related infections: Active release strategies. Chem Soc Rev 2006; 35: 780-789.
9. Stickler DJ,. Biomaterials to prevent nosocomial infections: Is silver the gold standard? Curr Opin Infect Dis 2000; 13: 389-393.
10. Stobie N, Duffy B, McCormack DE, Colreavy J, Hidalgo M, McHale P, Hinder SJ,. Prevention of Staphylococcus epidermidis biofilm formation using a low-temperature processed silver-doped phenyltriethoxysilane sol-gel coating. Biomaterials 2008; 29: 963-969.
11. Silver S,. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003; 27: 341-353.
12. Wan AT, Conyers RA, Coombs CJ, Masterton JP,. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 1991; 37: 1683-1687.
13. Hardes J, Ahrens H, Gebert C, Streitbuerger A, Buerger H, Erren M, Gunsel A, Wedemeyer C, Saxler G, Winkelmann W, Gosheger G,. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials 2007; 28: 2869-2875.
14. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W,. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006; 60: 648-652.
15. Eliopoulos GM, Eliopoulos CT,. Antibiotic combinations: Should they be tested? Clin Microbiol Rev 1988; 1: 139-156.
16. Cottarel G, Wierzbowski J,. Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol 2007; 25: 547-555.
17. Berenbaum M,. A method for testing for synergy with any number of agents. J Infect Dis 1978; 137: 122-130.
18. Li P, Li J, Wu C, Wu Q, Li J,. Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005; 16: 1912.
19. Privett BJ, Deupree SM, Backlund CJ, Rao KS, Johnson CB, Coneski PN, Schoenfisch MH,. Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens. Mol Pharm 2010; 7: 2289-2296.
20. Logghe C, Van Ossel C, D'hoore W, Ezzedine H, Wauters G, Haxhe J,. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: A randomized controlled trial. J Hosp Infect 1997; 37: 145-156.
21. Marxer SM, Rothrock AR, Nablo BJ, Robbins ME, Schoenfisch MH,. Preparation of nitric oxide (NO)-releasing sol-gels for biomaterial applications. Chem Mater 2003; 15: 4193-4199.
22. MacMicking J, Xie QW, Nathan C,. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-350.
23. Hetrick EM, Schoenfisch MH,. Antibacterial nitric oxide-releasing xerogels: Cell viability and parallel plate flow cell adhesion studies. Biomaterials 2007; 28: 1948-1956.
24. Nichols SP, Schoenfisch MH,. Nitric oxide flux-dependent bacterial adhesion and viability at fibrinogen-coated surfaces. Biomater Sci 2013; 11151-11159.
25. Cai W, Wu J, Xi C, Meyerhoff ME,. Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings. Biomaterials 2012; 33: 7933-7944.
26. Holt J, Hertzberg B, Weinhold P, Storm W, Schoenfisch M, Dahners L,. Decreasing bacterial colonization of external fixation pins via nitric oxide release coatings. J Orthop Trauma 2011; 25: 432-437.
27. Nablo BJ, Prichard HL, Butler RD, Klitzman B, Schoenfisch MH,. Inhibition of implant-associated infections via nitric oxide release. Biomaterials 2005; 26: 6984-6990.
28. Storm W, Schoenfisch MH,. Nitric oxide-releasing xerogels synthesized from N-diazeniumdiolate-modified silane precursors. ACS Appl Mater Interfaces 2013; 5: 4904-4912.
29. Radin S, Ducheyne P,. Controlled release of vancomycin from thin sol-gel films on titanium alloy fracture plate material. Biomaterials 2007; 28: 1721-1729.
30. Bruehlman RJ, Verhoek FH,. The basic strengths of amines as measured by the stabilities of their complexes with silver ions. J Am Chem Soc 1948; 70: 1401-1404.
31. Manna A, Imae T, Iida M, Hisamatsu N,. Formation of silver nanoparticles from a N-Hexadecylethylenediamine silver nitrate complex. Langmuir 2001; 17: 6000-6004.
32. Stokes RH, Walton HF,. Metal-amine complexes in ion exchange. J Am Chem Soc 1954; 76: 3327-3331.
33. Shin JH, Marxer SM, Schoenfisch MH,. Nitric oxide-releasing sol-gel particle/polyurethane glucose biosensors. Anal Chem 2004; 76: 4543-4549.
34. Brouqui P, Rousseau M, Stein A, Drancourt M, Raoult D,. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 1995; 39: 2423-2425.
35. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, Baere GAJ, Kluytmans JA,. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21: 319-323.
36. Marini M, De Niederhausern S, Iseppi R, Bondi M, Sabia C, Toselli M, Pilati F,. Antibacterial activity of plastics coated with silver-doped organic-inorganic hybrid coatings prepared by sol-gel processes. Biomacromolecules 2007; 8: 1246-1254.
37. Berenbaum MC,. Minor synergy and antagonism may be clinically important. J Antimicrob Chemother 1987; 19: 271-273.
38. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH,. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 2008; 74: 2171-2178.
39. Nablo BJ, Schoenfisch MH,. Poly(vinyl chloride)-coated sol-gels for studying the effects of nitric oxide release on bacterial adhesion. Biomacromolecules 2004; 5: 2034-2041.
40. Triandafillu K, Balazs DJ, Aronsson BO, Descouts P, Tu Quoc P, van Delden C, Mathieu HJ, Harms H,. Adhesion of Pseudomonas aeruginosa strains to untreated and oxygen-plasma treated poly(vinyl chloride) (PVC) from endotracheal intubation devices. Biomaterials 2003; 24: 1507-1518.
41. Gusarov I, Shatalin K, Starodubtseva M, Nudler E,. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 2009; 325: 1380-1384.
42. Levelt CN, Eichmann K,. Streptavidin-tricolor is a reliable marker for nonviable cells subjected to permeabilization or fixation. Cytometry 1994; 15: 84-86.
43. Park HJ, Kim JY, Kim J, Lee JH, Hahn JS, Gu MB, Yoon J,. Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity. Water Res 2009; 43: 1027-1032.
44. Hetrick EM, Shin JH, Stasko NA, Johnson CB, Wespe DA, Holmuhamedov E, Schoenfisch MH,. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2008; 2: 235-246.
45. Nablo BJ, Schoenfisch MH,. In vitro cytotoxicity of nitric oxide-releasing sol-gel derived materials. Biomaterials 2005; 26: 4405-4415.
46. Hidalgo E, Dombox drawings light down and leftnguez C,. Study of cytotoxicity mechanisms of silver nitrate in human dermal fibroblasts. Toxicol Lett 1998; 98: 169-179.
47. Radi R, Beckman JS, Bush KM, Freeman BA,. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266: 4244-4250.
48. Beckman JS, Koppenol WH,. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437.